Cancer Immunology Connect is a peer-reviewed, open-access journal dedicated to understanding of the complex interactions between cancer cells and the immune system. The journal aims to publish innovative research and promote the dissemination of significant discoveries in cancer immunology.
Scope:
- Tumor immunology: mechanisms of immune evasion and tumor progression.
- Cancer immunotherapy: development and efficacy of immune-based treatments.
- Immuno-oncology: combination therapies and their impact on the tumor microenvironment.
- Immune cell signaling in cancer: pathways and molecular mechanisms.
- Biomarkers for immunotherapy: discovery and clinical validation.
- Translational research: from bench to bedside applications.
- Clinical trials: results and implications for future cancer treatments.
- Case studies: novel immunotherapeutic approaches and patient outcomes.
- Reviews and perspectives: current trends and future directions in cancer immunology.
- Methodological advancements: innovative techniques for studying cancer-immune interactions.
Cancer Immunology Connect provides a platform for researchers, clinicians, and practitioners to share their findings, discuss challenges, and explore new frontiers in the fight against cancer through immunological approaches.
